CHTR(CHTR)
CHTR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $54.31B | $53.91B | $54.12B | $54.74B | $55.30B |
| Low | $54.10B | $52.19B | $54.12B | $53.78B | $54.33B |
| High | $54.60B | $54.78B | $54.13B | $55.39B | $55.95B |
| EBITDA Avg | $21.32B | $21.17B | $21.25B | $21.49B | $21.71B |
| Low | $21.24B | $20.49B | $21.25B | $21.11B | $21.33B |
| High | $21.43B | $21.51B | $21.25B | $21.74B | $21.97B |
| EBIT Avg | $14.01B | $13.91B | $13.96B | $14.12B | $14.27B |
| Low | $13.96B | $13.46B | $13.96B | $13.87B | $14.02B |
| High | $14.09B | $14.13B | $13.96B | $14.29B | $14.44B |
| Net Income Avg | $5.21B | $6.25B | $5.07B | $7.63B | $8.93B |
| Low | $5.05B | $5.67B | $4.07B | $7.45B | $8.73B |
| High | $6.08B | $6.82B | $10.06B | $7.74B | $9.07B |
| EPS Avg | $41.21 | $45.35 | $53.92 | $55.38 | $64.86 |
| Low | $36.65 | $41.15 | $29.54 | $54.11 | $63.37 |
| High | $44.12 | $49.53 | $73.04 | $56.22 | $65.85 |
| Analysts (Rev / EPS) | 14 / 13 | 14 / 13 | 14 / 12 | 9 / 10 | 13 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $13.54B | $13.56B | $13.62B | $13.50B | $13.45B | $13.39B | $13.44B |
| Low | $13.37B | $13.38B | $13.47B | $13.35B | $13.30B | $13.24B | $13.29B |
| High | $13.67B | $13.71B | $13.76B | $13.64B | $13.58B | $13.52B | $13.58B |
| EBITDA Avg | $5.32B | $5.32B | $5.35B | $5.30B | $5.28B | $5.26B | $5.28B |
| Low | $5.25B | $5.25B | $5.29B | $5.24B | $5.22B | $5.20B | $5.22B |
| High | $5.37B | $5.38B | $5.40B | $5.35B | $5.33B | $5.31B | $5.33B |
| EBIT Avg | $3.49B | $3.50B | $3.51B | $3.48B | $3.47B | $3.45B | $3.47B |
| Low | $3.45B | $3.45B | $3.48B | $3.44B | $3.43B | $3.42B | $3.43B |
| High | $3.53B | $3.54B | $3.55B | $3.52B | $3.50B | $3.49B | $3.50B |
| Net Income Avg | $1.30B | $1.29B | $1.53B | $1.30B | $1.33B | $1.34B | $1.52B |
| Low | $1.19B | $899M | $1.51B | $1.28B | $1.31B | $1.32B | $1.50B |
| High | $1.42B | $1.48B | $1.55B | $1.32B | $1.35B | $1.36B | $1.54B |
| EPS Avg | $10.22 | $10.21 | $12.07 | $10.26 | $10.52 | $10.55 | $11.98 |
| Low | $9.41 | $7.09 | $11.89 | $10.11 | $10.36 | $10.39 | $11.81 |
| High | $11.22 | $11.64 | $12.23 | $10.40 | $10.65 | $10.68 | $12.14 |
| Analysts (Rev / EPS) | 11 / 11 | 9 / 10 | 8 / 4 | 4 / 4 | 4 / 4 | 5 / 4 | 4 / 4 |